U.S. market Closed. Opens in 12 hours 5 minutes

PBYI | Puma Biotechnology, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for PBYI we got that it has average fundamentals where Valuation is considered to be undervalued, Profitability is moderate, Growth is exceptionally good and Health is frighteningly weak.

Valuation (76%)

Company Industry
P/E Ratio (TTM) 6.43 -18.81
PEG Ratio (TTM) 0.04 -5.53
P/S Ratio (TTM) 0.61 47.66
P/B Ratio (TTM) 2.10 31.59
P/FCF Ratio (TTM) 4.45 -3.70
Price to 5YR AVG Earnings Ratio -3.92 -7.63
Price to 5YR AVG FCF Ratio 49.52 -14.42

Profitability (55%)

Company Industry
ROA (TTM) 10.53% -16.98%
ROE (TTM) 41.50% 27.27%
Net Profit Margin (TTM) 9.54% -682.28%
ROIC 5YR AVG -7.39% -3.58%

Growth (85%)

4QTR AVG 3YR AVG 5YR AVG
EPS 130.36% 36.68% 473.55%
Revenue 16.98% 1.21% -0.59%
Net Income 131.74% 35.38% 495.34%
Cash Flow 222.49% 861.34% 535.73%

Health (26%)

Company Industry
Current Ratio (TTM) 1.42 5.71
Quick Ratio (TTM) 1.40 5.49
D/E Ratio (TTM) 1.10 1.09
Interest Coverage (TTM) 2.46 -7.46
Piotroski F-Score 5 5
Altman Z-Score N/A 12.74
LTL to 5YR AVG FCF 24.04 0.06
Shares Outstanding Growth 5YR AVG 4.48% 40.20%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙